Cannara Biotech Inc. LOVE.TO
TSX
| 05/31/2026 | 02/28/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 15.31% | -8.32% | |||
| Total Other Revenue | 1,524.58% | 0.42% | |||
| Total Revenue | 17.14% | -8.31% | |||
| Cost of Revenue | 8.18% | -16.53% | |||
| Gross Profit | 29.09% | 5.56% | |||
| SG&A Expenses | -6.59% | -3.01% | |||
| Depreciation & Amortization | -5.76% | -3.66% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.94% | -11.87% | |||
| Operating Income | 116.40% | 27.88% | |||
| Income Before Tax | 143.81% | 40.37% | |||
| Income Tax Expenses | 75.49% | 17.40% | |||
| Earnings from Continuing Operations | 191.35% | 62.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 191.35% | 62.49% | |||
| EBIT | 116.40% | 27.88% | |||
| EBITDA | 92.35% | 11.90% | |||
| EPS Basic | 183.33% | 59.49% | |||
| Normalized Basic EPS | 128.06% | 41.84% | |||
| EPS Diluted | 183.33% | 75.00% | |||
| Normalized Diluted EPS | 128.68% | 43.16% | |||
| Average Basic Shares Outstanding | 2.52% | 2.82% | |||
| Average Diluted Shares Outstanding | 2.13% | 2.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||